Toxoplasmosis - Pipeline Review, H2 2014

Publisher Name :
Date: 25-Oct-2014
No. of pages: 24
Inquire Before Buying
Offers on Market Research Reports at RnRMarketResearch.com

Toxoplasmosis - Pipeline Review, H2 2014

Summary

Global Markets Direct's, ‘Toxoplasmosis - Pipeline Review, H2 2014', provides an overview of the Toxoplasmosis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Toxoplasmosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Toxoplasmosis and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Toxoplasmosis

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Toxoplasmosis and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Toxoplasmosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

- Coverage of the Toxoplasmosis pipeline on the basis of target, MoA, route of administration and molecule type

- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop strategic initiatives by understanding the focus areas of leading companies

- Identify and understand important and diverse types of therapeutics under development for Toxoplasmosis

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Devise corrective measures for pipeline projects by understanding Toxoplasmosis pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Toxoplasmosis - Pipeline Review, H2 2014

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Toxoplasmosis Overview 5
Therapeutics Development 6
Pipeline Products for Toxoplasmosis - Overview 6
Pipeline Products for Toxoplasmosis - Comparative Analysis 7
Toxoplasmosis - Therapeutics under Development by Companies 8
Toxoplasmosis - Therapeutics under Investigation by Universities/Institutes 9
Toxoplasmosis - Pipeline Products Glance 10
Early Stage Products 10
Toxoplasmosis - Products under Development by Companies 11
Toxoplasmosis - Products under Investigation by Universities/Institutes 12
Toxoplasmosis - Companies Involved in Therapeutics Development 13
Snowdon Inc. 13
Toxoplasmosis - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Molecule Type 15
Drug Profiles 17
SND-226 - Drug Profile 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
toxoplasmosis vaccine (SAG1) - Drug Profile 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
toxoplasmosis vaccine - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SNT-18 - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Monoclonal Antibody for Toxoplasmosis - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Toxoplasmosis - Dormant Projects 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Number of Products under Development for Toxoplasmosis, H2 2014 6
Number of Products under Development for Toxoplasmosis - Comparative Analysis, H2 2014 7
Number of Products under Development by Companies, H2 2014 8
Number of Products under Investigation by Universities/Institutes, H2 2014 9
Comparative Analysis by Early Stage Development, H2 2014 10
Products under Development by Companies, H2 2014 11
Products under Investigation by Universities/Institutes, H2 2014 12
Toxoplasmosis - Pipeline by Snowdon Inc., H2 2014 13
Assessment by Monotherapy Products, H2 2014 14
Number of Products by Stage and Molecule Type, H2 2014 16
Toxoplasmosis - Dormant Projects, H2 2014 22

List of Figures
Number of Products under Development for Toxoplasmosis, H2 2014 6
Number of Products under Development for Toxoplasmosis - Comparative Analysis, H2 2014 7
Number of Products under Investigation by Universities/Institutes, H2 2014 9
Comparative Analysis by Early Stage Products, H2 2014 10
Assessment by Monotherapy Products, H2 2014 14
Number of Products by Top 10 Molecule Type, H2 2014 15
Number of Products by Stage and Top 10 Molecule Type, H2 2014 16
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Current State of Blood Banking Market, Products, Technologies and Services
    The global blood banking and blood products market is expected to reach US$41.9 billion by 2020 with USA continuing to be the largest market worldwide. Asia-Pacific follows a close second with a projected CAGR of 9.1% during this period owing to the refining healthcare infrastructure and increase in the per capita healthcare expenditure. The major [...]
  • Surgical Robots Market 2016 Updates on Companies, Products and More
    Surgical robots are medical devices that assist surgeons in performing many types of complex procedures with more accuracy, flexibility and control than is possible with conventional techniques. The aim of surgical robots market players is to provide improved diagnostic skills, a less invasive and more comfortable experience for the patient, and the ability to do [...]
  • International Wound Cleanser Industry 2019 Forecasts with Feasibility Study of Future Projects
    ‘Market Research Report on Global and Chinese Wound Cleanser Industry, 2009-2019’ is a comprehensive market research report that offers top-notch industry insights and analyzes the growth prospects of the industry, along with evaluating the up-surging opportunities in the Global and Chinese market over the forecast period of 2014-2019. The methodically planned sections of the research [...]
  • United States Cephalosporin Drug Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 3800 Onwards        Pages: 130
    The United States Cephalosporin Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cephalosporin Drug industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cephalosporin Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.......
  • Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Industry 2016 Market Research Report
    Published: 16-Jun-2016        Price: US 2800 Onwards        Pages: 157
    The Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections market analysis is provided......
  • Global Cytomegalovirus Therapeutic Industry 2016 Market Research Report
    Published: 13-Jun-2016        Price: US 2800 Onwards        Pages: 154
    The Global Cytomegalovirus Therapeutic Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Cytomegalovirus Therapeutic industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Cytomegalovirus Therapeutic market analysis is provided for the international market including development history, competitive landscape analysis, and major......
  • Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Market Professional Survey Report 2016
    Published: 08-Jun-2016        Price: US 3500 Onwards        Pages: 114
    This report mainly covers the following Product types including Vancomycin Linezolid Quinupristin/dalfopristin Daptomycin Tigecycline Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested in can also be added) Pfizer......
  • Global Niclosamide Market Professional Survey Report 2016
    Published: 07-Jun-2016        Price: US 3500 Onwards        Pages: 108
    This report mainly covers the following Product types including Tablet Capsule Injection The segment applications including Hospital use Clinic use Household Segment regions including (the separated region report can also be offered) North America Europe Japan China Southeast Asia India The players list (Partly, Players you are interested......
  • Global Common Cold Partnering 2010-2016
    Published: 01-Jun-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the common cold partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends......
  • Global E-Coli Partnering 2010-2016
    Published: 01-Jun-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the e-coli partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in p......
  • EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2025
    Published: 01-Jun-2016        Price: US 3995 Onwards        Pages: 82
    EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2025 Summary Invasive meningococcal disease (IMD) is a life-threatening condition caused by the bacterium Neisseria meningitidis (N. meningitidis), an encapsulated gram-negative diplococcus that is a pathogen exclusive to humans. N. meningitidis is carried harmlessly in the nasopharynx of approximately 5?11% of adults and up to 25% of adolescents. Life-threatening disease occurs when the bacterium inva......
  • Global MRSA Partnering 2010 to 2016
    Published: 01-Jun-2016        Price: US 1495 Onwards        Pages: 150
    "Delivery of this report will take 1-3 days after purchase." Summary Provides understanding and access to the MRSA partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in par......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs